PrEP use and HIV seroconversion rates in adolescent girls and young women from Kenya and South Africa: the POWER demonstration project
Connie Celum(University of Washington), Rachel Johnson(National Institute for Biological Standards and Control), Lauren D. Kudrick(University of Pittsburgh), Susan Morrison, Elizabeth A. Bukusi(University of California, San Francisco), Linda‐Gail Bekker(Desmond Tutu HIV Foundation), Linxuan Wu(University of Washington), Gabrielle O’Malley(Office of the National Coordinator for Health Information Technology), Felix Mogaka(University of Washington), Peter L. Anderson(University of Colorado Denver), Gena Barnabee(University of Washington), Lara Kidoguchi, Renee Heffron(University of Washington), Jared M. Baeten(University of Washington), Deborah Donnell(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Jessica E. Haberer(Massachusetts General Hospital), Ariane van der Straten(University of California, San Francisco), Sinéad Delany‐Moretlwe(University of Cape Town), Elzette Rousseau(Desmond Tutu HIV Foundation), Victor Omollo(Kenya Medical Research Institute), Urvi M. Parikh(University of Pittsburgh), Danielle Travill(University of the Witwatersrand), Jennifer F. Morton(University of Washington)
Cited by 95
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
|New England Journal of Medicine|2016|768